Song et al.28 observed that resistance to a nanoparticle-bound paclitaxel (nab-PTX) developed in 3 ESCC tumor lines in vitro and was associated with greater PP2A expression and stabilization of the anti-apoptotic protein MCL1. Here, MCL1 is linked to neoplasm.